Cellectar Biosciences, Inc. · NASDAQ:CLRB

Stempoint Capital LP reported a 9.90% stake in Cellectar Biosciences, Inc. (Schedule 13G)

Event Jun 30, 2026 · Filed Aug 14, 2026

Stempoint Capital LP reported a 9.90% stake in Cellectar Biosciences, Inc., 845,740 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G).

Stake
9.90%
Shares
845,740
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
StemPoint Capital LP9.90%845,740
StemPoint Capital Management GP LLC9.90%845,740
Michelle Ross9.90%845,740

Source

View original at SEC

Related